Effects of Different Doses of Butorphanol on Perioperative Analgesia, Recovery, and Immune Function in Patients Undergoing Cytoreductive Surgery for Ovarian Cancer: A Randomized Controlled Trial
High-dose butorphanol PCIA effectively relieves postoperative pain and reduces time to early ambulation without affecting immune indicators within 48 h postoperatively.
Authors
- Tingting Tian
- Guizhi Wang (ORCID: https://orcid.org/0000-0002-9003-9640)
- N N Zhang (ORCID: https://orcid.org/0009-0009-6816-550X)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-5292-7308)
- Mengmeng Xu (ORCID: https://orcid.org/0000-0002-9456-6720)
- Chuanyao Li (ORCID: https://orcid.org/0000-0002-9263-7708)
- Chen Gao (ORCID: https://orcid.org/0000-0002-2860-4784)
Institutions
- University of Science and Technology of China (CN)
- Bengbu Medical College (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/dddt.s545111
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- CIEE Ping Foundation